Minneapolis, MN, April 14, 2026 (GLOBE NEWSWIRE) — NightWare, Inc. and Exit 156 Capital immediately collectively introduced a strategic funding by Exit 156 in NightWare’s ongoing Sequence C financing. NightWare is the maker of the one FDA-cleared prescription digital therapeutic indicated for nightmare dysfunction in adults with post-traumatic stress dysfunction (PTSD). The partnership unites a Minneapolis-based growth-stage digital well being firm with a Minneapolis-area funding agency whose experience spans healthcare providers, units, and know-how — deepening a relationship that started with Exit 156 Founding Accomplice Mike Nathan’s early involvement as a NightWare investor and advisor.
The funding will speed up NightWare’s nationwide VA Pathfinder Innovation Pilot, scale business employer-group insurance coverage pilots with first responder organizations, advance proprietary {hardware} growth, and develop the corporate’s affected person administration program towards a recurring income mannequin. NightWare’s Sequence C is being raised at a $10 million pre-money valuation, with $1.4 million already secured and $2.0 million of fairness remaining obtainable to certified buyers.
A Partnership Rooted in Mission and Market Conviction
The NightWare-Exit 156 partnership displays shared conviction about each the severity of the unmet scientific want and the energy of the business basis NightWare has constructed. Nightmare dysfunction impacts an estimated 71–96% of people with PTSD and is independently related to suicidality, but most PTSD remedy protocols don’t embody a device-based intervention particularly concentrating on nightmares. NightWare addresses this hole with an FDA-cleared, AI-guided wearable system that intervenes through the nightmare cycle — with out waking the affected person.
For Exit 156, the funding suits squarely inside the agency’s concentrate on healthcare know-how corporations with defensible market positions and confirmed administration groups. For NightWare, Exit 156 brings not solely capital however a community of healthcare working companions, a flat and decisive funding construction, and twenty years of expertise constructing and scaling healthcare corporations within the Minneapolis ecosystem.
More Read
“Exit 156 doesn’t invest in categories — they invest in people and proof. We have both. This partnership accelerates our path to standard reimbursement coverage in the VA, deeper penetration in first responder markets, and the commercial infrastructure needed to make NightWare the standard of care for nightmare disorder nationwide.”
— Matt Tucker, CEO, NightWare, Inc.
“Mike Nathan’s early belief in NightWare helped set the stage for this partnership. When we looked at the full picture, the clinical evidence, the reimbursement in place, the VA pilot, and a team that knows how to execute, the decision to invest at the Series C level was clear.”
More Read
— Josh Robinson, Managing Accomplice, Exit 156 Capital
NightWare: Scientific Basis and Industrial Traction
NightWare’s system pairs an Apple Watch with a proprietary AI software that constantly screens coronary heart fee and motion throughout sleep, calculates a real-time stress index, and delivers personalised vibrotactile stimulation to interrupt the physiological escalation related to nightmares — with out totally waking the affected person. The machine is up to date and personalised nightly primarily based on prior session knowledge.
In a sham-controlled randomized scientific trial, high-usage sufferers demonstrated statistically important enhancements in general sleep high quality as measured by the Pittsburgh Sleep High quality Index (PSQI) — the gold-standard instrument in scientific sleep analysis. The corporate has achieved De Novo 510(okay) FDA clearance and holds Breakthrough Gadget Designation.
Sufferers Served: 2,000+Income Generated: $7.5M+Affected person Satisfaction*: 85%+Pre-Cash Valuation: $10M
*Amongst sufferers enrolled in NightWare’s Affected person Administration Program.
More Read
NightWare has generated greater than $7.5 million in cumulative income with a mean promoting worth of roughly $5,000 per machine and a gross margin exceeding 75%. The corporate is within the course of of creating reimbursement throughout VA well being system, business insurance coverage, and direct-pay channels. Its nationwide VA Pathfinder Innovation Pilot — a proper program designed to judge rising applied sciences for potential system-wide adoption — is presently lively on the Pittsburgh VA medical middle, with further websites onboarding within the subsequent 3 months.
Use of Proceeds
Speed up and develop the nationwide VA Pathfinder Innovation Pilot throughout a number of VA medical middle websites Scale employer-group business insurance coverage pilots with fireplace and police departments to attain covered-benefit standing Commercialize the affected person administration program as a per-patient, per-month recurring income service Assist regulatory submission to the Israel Ministry of Well being for worldwide market entry File provisional patent software for brand new intervention sample rising accuracy and specificity
The Minneapolis MedTech Connection
Each NightWare and Exit 156 Capital are deeply rooted within the Minneapolis-Minnesota healthcare and know-how ecosystem — a area that has produced a number of the world’s most important medtech corporations and a rising class of digital well being innovators. Exit 156’s founders are graduates of Saint John’s College in Collegeville, Minnesota, and constructed their careers within the Twin Cities healthcare market. NightWare has grown inside and alongside that ecosystem, drawing on the area’s scientific relationships, investor networks, and expertise base.
“There is something about how this team has built the company,” stated Josh Robinson. “You see a bit of that Minnesota mindset in it. Thoughtful. Grounded in integrity. Focused on long term value, not short-term noise. NightWare reflects that in all the right ways, and this partnership is a natural fit.”
Investor Entry
NightWare’s Sequence C financing stays open to certified buyers. $2.0 million in fairness is on the market at $0.51 per share on a $10 million pre-money valuation. Traders all for reviewing the chance are invited to go to www.fundnightware.com or contact NightWare on to request knowledge room entry and schedule a administration assembly.
Investor Inquiry
www.fundnightware.com | matthew [at] nightware.com
About NightWare, Inc.
NightWare, Inc. is a Minneapolis-based digital well being firm and developer of the one FDA-cleared prescription digital therapeutic indicated for nightmare dysfunction in adults with post-traumatic stress dysfunction (PTSD). The NightWare system pairs an Apple Watch with a proprietary AI software to observe sleep physiology and ship personalised, non-awakening vibrotactile interventions that disrupt the nightmare cycle. NightWare holds De Novo 510(okay) FDA clearance and Breakthrough Gadget Designation. The corporate serves sufferers throughout VA well being system, business, and direct-pay channels and is presently executing a nationwide VA Pathfinder Innovation Pilot. NightWare is a prescription machine. It’s not a standalone remedy for PTSD and needs to be used along with clinician-directed care. Particular person outcomes might range. www.nightware.com
About Exit 156 Capital
Exit 156 Capital is an funding agency targeted on non-controlling investments in growth-stage corporations throughout healthcare providers, units, and know-how. The agency companions with confirmed administration groups constructing significant, sturdy companies and appears for alternatives the place it might probably contribute past capital.
Based by operators with deep expertise in healthcare and know-how, Exit 156 takes a people-first method and works carefully with its portfolio corporations on technique, development, and execution. The agency invests with a disciplined concentrate on long-term worth creation and seeks to help groups constructing corporations that matter within the markets they serve. exit156.com
Press Inquiries
NightWare Media ContactMatt Tucker, CEOmatthew [at] nightware.comhttps://nightware.com/https://fundnightware.com/
Exit 156 Capital Media ContactJosh Robinson, Managing PartnerJosh [at] exit156.comhttps://exit156.com/
